The present study was designed to investigate the effects of chronic exposure to high GLP-1 levels (as experienced by T2DM patients treated with GLP-1 analogues or DPP-4-inhibitors) on cultured pancreatic alpha cells (α-TC1 clone 6). The gene discussed is DPP4; the disease is type 2 diabetes mellitus.